Hodgkin lymphoma is among the most curable cancers. For patients in remission for 24 months, residual lifetime becomes close to that of the background population. However, late relapses can occur after several years and, as shown by Andersen et al., the outcomes are not always good
Background: High-dose chemotherapy has an established role in recurrent or refractory Hodgkin's lymp...
PURPOSE: Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma...
The use of routine imaging for patients with classical Hodgkin lymphoma (HL) in complete remission (...
Hodgkin lymphoma is among the most curable cancers. For patients in remission for 24 months, residua...
It is claimed that late relapses of Hodgkin's disease have a good prognosis when retreated. A number...
In the past several decades, scientific and therapeutic advances have transformed Hodgkin's disease ...
Purpose Clinical characteristics, therapeutic approaches, and prognosis of late relapse (LR) in pati...
Background Given the impressive long-term remission rates in recent years, current clinical research...
Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma (cHL) ar...
Five patients whose Hodgkin's disease recurred 10 years or more after the achievement of complete re...
PURPOSE We evaluated disease and treatment characteristics of patients with relapse after risk-adapt...
Purpose Progression or relapse of Hodgkin lymphoma (HL) is common among older patients. However, pro...
As a consequence of the impressive long-term remission rates in Hodgkin's lymphoma (HL) patients, cu...
This study was focused on 96 patients with Hodgkin lymphoma: After ten years, 88% patients are alive...
PURPOSE We evaluated disease and treatment characteristics of patients with relapse after risk-ad...
Background: High-dose chemotherapy has an established role in recurrent or refractory Hodgkin's lymp...
PURPOSE: Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma...
The use of routine imaging for patients with classical Hodgkin lymphoma (HL) in complete remission (...
Hodgkin lymphoma is among the most curable cancers. For patients in remission for 24 months, residua...
It is claimed that late relapses of Hodgkin's disease have a good prognosis when retreated. A number...
In the past several decades, scientific and therapeutic advances have transformed Hodgkin's disease ...
Purpose Clinical characteristics, therapeutic approaches, and prognosis of late relapse (LR) in pati...
Background Given the impressive long-term remission rates in recent years, current clinical research...
Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma (cHL) ar...
Five patients whose Hodgkin's disease recurred 10 years or more after the achievement of complete re...
PURPOSE We evaluated disease and treatment characteristics of patients with relapse after risk-adapt...
Purpose Progression or relapse of Hodgkin lymphoma (HL) is common among older patients. However, pro...
As a consequence of the impressive long-term remission rates in Hodgkin's lymphoma (HL) patients, cu...
This study was focused on 96 patients with Hodgkin lymphoma: After ten years, 88% patients are alive...
PURPOSE We evaluated disease and treatment characteristics of patients with relapse after risk-ad...
Background: High-dose chemotherapy has an established role in recurrent or refractory Hodgkin's lymp...
PURPOSE: Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma...
The use of routine imaging for patients with classical Hodgkin lymphoma (HL) in complete remission (...
DOI
Add to ORKG